Posted on October 11th, 2024 by Academic Programs
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Posted on October 11th, 2024 by Academic Programs
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Posted on October 11th, 2024 by Academic Programs
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Posted on October 11th, 2024 by Academic Programs
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Posted on October 10th, 2024 by Academic Programs
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Opioid Dependence
Posted on October 10th, 2024 by Academic Programs
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Psychiatry
Posted on October 10th, 2024 by Academic Programs
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Alzheimer’s
Posted on October 10th, 2024 by Academic Programs
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Tardive Dyskinesia (TD)
Posted on October 10th, 2024 by Academic Programs
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Posted on October 10th, 2024 by Academic Programs
In this session, participants will review the mechanism of disease of schizophrenia and hear about the potential impact of novel agents in changing the landscape of schizophrenia treatment in addressing symptom domains and adverse event profiles.